Bile constituents in ascitic fluid.
Bile acids and other bile constituents were determined in serum and ascites from eight patients with liver cirrhosis and in ascites secondary to malignancy in six patients. In cirrhotic ascites, total bile acid levels averaged 53% of the serum levels. A positive correlation was evident between ascites and serum levels for both cholic and chenodeoxycholic acid. For cholic acid, the ascites to serum ratio was higher in all patients compared with the corresponding ratio for chenodeoxycholic acid. The ascites to serum ratios for glycine, taurine and sulphate conjugates were similar, no tendency being shown by any of the conjugates to leak more easily into ascites. The high levels of bile acids in cirrhotic ascites suggests that the abdominal cavity harbours a fraction of the bile acid pool, which should be taken into account when studying bile acid turnover in liver cirrhosis. Bilirubin levels in cirrhotic ascites averaged 24% of the serum values. A positive correlation between ascites and serum levels for unconjugated bilirubin was recorded, whereas the occurrence of bilirubin conjugates in ascites was variable. Albumin levels in cirrhotic ascites were 25% of the serum levels. The ascites to serum ratios for other proteins such as IgG, IgA and IgM and also cholesterol and phospholipids were lower than that for albumin. In malignant ascites, a pattern different from that in liver cirrhosis was seen, low bile acid levels being found. No difference between bilirubin levels was observed, while albumin and cholesterol levels were higher in malignant ascites, with no overlap between the patient groups. These results indicate that the complex mechanisms of ascites formation result in variable levels of bile constituents in ascitic fluid, which are further dependent on the underlying disease.
Hedenborg
G
G
Department of Clinical Chemistry, Karolinska Hospital, Stockholm, Sweden.
Jönsson
G
G
Norman
A
A
Wisén
O
O
D000368:Aged; D001202:Ascitic Fluid / Q000032:analysis*; D001647:Bile Acids and Salts / Q000032:analysis*; D001663:Bilirubin / Q000032:analysis; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D008055:Lipids / Q000032:analysis; D008104:Liver Cirrhosis, Alcoholic / Q000378:metabolism*; D008105:Liver Cirrhosis, Biliary / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000032:analysis*; D012709:Serum Albumin / Q000032:analysis
D001647:Bile Acids and Salts; D007136:Immunoglobulins; D008055:Lipids; D012709:Serum Albumin; D001663:Bilirubin